Sepsim

🗓 Founded 2025👥 2 employees💰 Last funded May 2025
Pharmaceutical Manufacturing🌐 sepsim.com
Website LinkedIn
Sepsim is a breakthrough biotech company developing a novel drug to combat Sepsis and MRSA—two of the deadliest threats in modern medicine. In preclinical animal trials, the results were nothing short of extraordinary: 100% survival in treated subjects, compared to 100% mortality in untreated controls. Our mission is clear and urgent: to solve Sepsis, a condition that claims millions of lives each year with limited effective treatments available. At Sepsim, we believe the cure starts here.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Sepsim?
Sepsim has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Sepsim last raise funding?
The most recent investment in Sepsim recorded on gritt.io was in May 2025.
When was Sepsim founded?
Sepsim was founded in 2025.
What industry is Sepsim in?
Sepsim operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.